Tag: tyrosine kinase inhibitor leukemia

Home / tyrosine kinase inhibitor leukemia

Categories

Quizartinib is approved by the FDA for newly diagnosed acute myeloid leukemia

August 2023: The treatment of adult patients with newly diagnosed acute myeloid leukaemia (AML) that is FLT3 internal tandem duplication (ITD)-positive, as detected by an FDA-approved test, with stan...
tyrosine-kinase-inhibitor-leukemia

Scan the code